Pricing Log in Create free account

Beta Bionics, Inc. (BBNX) vs Bioventus Inc. (BVS)

Beta Bionics, Inc. and Bioventus Inc. are both Medical Devices companies. Beta Bionics, Inc. and Bioventus Inc. are of similar size ($899.9M and $842.1M). Beta Bionics, Inc. has negative trailing earnings, so its P/E is not meaningful; Bioventus Inc. trades at 12.3×. Beta Bionics, Inc. grew revenue faster over the last twelve months: 43.7% against 3.87%. Bioventus Inc. has the higher net margin (9.78% vs −65.3%) and the higher return on invested capital (7.22% vs −35.9%). Across the 17 metrics below, Bioventus Inc. leads on 13 and Beta Bionics, Inc. on 4.

Valuation

Metric BBNX BVS Medical Devices median
P/E n/m 12.32 25.58
P/S 5.64 1.24 2.54
P/B 1.79 2.48 2.48
Price to free cash flow n/m 8.53 28.81
EV/EBITDA n/m 9.16 11.51
EV/Sales 3.75 1.58 2.72
Earnings yield (11.95%) 8.12% (12.82%)
Free cash flow yield (47.75%) 11.73% (8.18%)

Profitability

Metric BBNX BVS Medical Devices median
Gross margin 58.63% 68.70% 57.76%
Operating margin (72.75%) 9.69% (15.07%)
Net margin (65.31%) 9.78% (14.45%)
Free cash flow margin (269.28%) 14.51% (3.88%)
Return on equity (23.88%) 22.96% (10.35%)
Return on assets (21.48%) 8.33% (17.26%)
Return on invested capital (35.92%) 7.22% (5.27%)

Growth

Metric BBNX BVS Medical Devices median
Revenue growth (TTM) 43.69% 3.87% 10.41%
EPS growth (last fiscal year) 78.95% 158.93% 28.17%
Revenue growth, 5-year CAGR — 12.08% 15.74%
Net income growth, 5-year CAGR — 6.73% 0.00%

Health

Metric BBNX BVS Medical Devices median
Debt to equity 0.00 0.79 0.04
Current ratio 8.92 1.68 2.74
Net debt to EBITDA 3.19 2.40 0.54

Dividend

Metric BBNX BVS Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric BBNX BVS Medical Devices median
Market cap 842.14m 899.91m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack